Medical Device Studies: Regulatory Requirements and Adverse Event Reporting

An essential overview of medical device clinical evaluations, clinical investigations, post-market clinical follow up requirements and adverse event and vigilance reporting

1-2 Oct 2019

GBP 1,499
EUR 2,099
USD 2,338

Book now

Course overview

This seminar provides an essential overview of medical device clinical evaluations, clinical investigations and post-market clinical follow-up (PMCF) studies with particular emphasis on the adverse event reporting requirements during these studies. The course will concentrate mostly on the new Medical Device Regulations (MDR) with some references to the existing Medical Device Directives. It will provide a good introduction to medical device clinical studies and serve as an update for those with experience who need to keep abreast of the regulatory changes and the methods of handling adverse events during the study period. It also covers the new requirements regarding periodic safety update reports (PSURs) and the summary of safety and clinical performance.

Who should attend?

  • Regulatory affairs specialists
  • Quality assurance specialists
  • Clinical research associates
  • Junior clinical research associates
  • Professionals involved in reporting adverse events during pre- and post-market clinical studies

Programme day one

Clinical evaluation – an overview

  • What is a clinical evaluation?
  • How do you conduct a clinical evaluation?
  • The regulatory requirements pertaining to clinical evaluation

Clinical investigations – an overview

  • What is a clinical investigation?
  • When are clinical investigations needed?
  • The regulatory requirements

PMS and PMCF

  • What is PMS?
  • What is PMCF?
  • When are PMCF studies necessary?

Quiz on clinical evaluation, clinical investigation and PMCF

New requirements of the MDR

  • Summary of safety and clinical performance
  • Periodic safety update report (PSUR)

The Competent Authority and the Notified Body

  • What is their role in the above processes?
  • What are the responsibilities of the manufacturer?
  • What to communicate and when

Workshop on the new requirements of the MDR

Programme day two

Review of day one

Vigilance reporting

  • What is vigilance?
  • The requirements for vigilance reporting during medical device studies

How to define and classify adverse events

  • Definitions
  • Types of events
  • Determining categories

Vigilance workshop

The regulatory requirements for monitoring and reporting adverse events during regulatory and PMCF studies

  • MEDDEV guidance document
  • ISO 14155 harmonised standard
  • Responsibilities
  • Templates

The MDR – clinical elements

  • Focus on changes in the clinical arena
  • Chapter 6: clinical evaluation and investigation
  • Annex 14: clinical evaluation and post-market clinical follow-up

Discussion session and end of seminar

Book now

1-2 Oct 2019
1-2 Oct 2019 Rembrandt Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Agency for Medicinal Products and Medical Devices of Croatia (HALMED)
  • BIOTRONIK AG
  • Croatian Agency for Medicinal Products and Medical Devices
  • Emas Pharma Ltd
  • Ferring Pharmaceuticals
  • Flexicare Medical Limited
  • Geistlich Pharma
  • GlaxoSmithKline
  • GlaxoSmithKline Consumer Healthcare
  • Guerbet
  • Institut Straumann AG
  • Larix A/S
  • Medpace UK
  • Novella Clinical
  • Premier Research Poland Sp. z o.o.
  • Syneos Health
  • Thornton & Ross Ltd
  • University of Cambridge
  • William Cook Europe
  • Xiros Ltd

Was really good and you could tell it was a passion for the presenter which is always nice and dealt with a difficult person asking questions well at the beginning.

Jason Hemmings, Manager, Syneos Health

Kath was very welcoming and presented well and in a way which I was able to understand. She used very good examples to help us understand the topic. I really enjoyed the course and felt it gave me a good insight and foundation to medical device studies.

Pavendeep Kumar, Principle Safety Specialist, Syneos Health

Speaker was very knowledgeable.

Tracy Best, Quality Assurance Manager, Flexicare Medical Limited

[The speaker was] very knowledgable, [and a] clear communicator.

Iris Koenig, Director , Larix A/S

Very useful course, excellent speaker.

Gianluca Musolino, Clinical Research Fellow, University of Cambridge

Very clear and understandable

Alison Etchells, Regulatory Affairs Officer, Thornton & Ross Ltd

Well prepared speaker - Good use of subjects

Emil Hofdahl, Specialist, Clinical Safety Reporting, William Cook Europe

Speakers were friendly, patient and easy to approach

Imogen Burkinshaw, Safety Reporting Manager, Novella Clinical

It was good and the content gave a lot of information on medical devices. The speaker was very knowledgeable about topic.

Roshini Nellailingam, Regulatory Affairs Manager, Emas Pharma Ltd

Very well structured. Did well to present this content in one day.

Goranka Marusic Kontent , European Affairs Advisor , Agency for Medicinal Products and Medical Devices of Croatia (HALMED)

Very detailed and informative presentation

Rukhnoor Mahmood, Project Manager, Emas Pharma Ltd